Identification and characterization of m1 selective muscarinic receptor antagonists

被引:9
|
作者
Augelli-Szafran, CE
Blankley, CJ
Jaen, JC
Moreland, DW
Nelson, CB
Penvose-Yi, JR
Schwarz, RD
Thomas, AJ
机构
[1] Parke Davis Pharmaceut Res, Dept Med Chem, Ann Arbor, MI 48105 USA
[2] Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA
关键词
D O I
10.1021/jm980067l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of esters of 1,4-disubstituted tetrahydropyridine carboxylic acids (I) has been synthesized and characterized as potential mi selective muscarinic receptor antagonists. The affinity of these compounds for the five human muscarinic receptor subtypes (Hm1-Hm5) was determined by the displacement of [H-3]-NMS binding using membranes from transfected Chinese hamster ovarian cells. One of the most potent and selective compounds of this series is an analogue of I [11, R-1 = (CH2)(5)CH3], which has an IC50 value of 27.3 nM at the m1 receptor and possesses 100-fold (m2), 48-fold (m3), 74-fold (m4), and 19-fold (m5) selectivities at the other receptors. Thus, this analogue appears to be more selective on the basis of binding than the prototypical mi antagonist, pirenzepine. Functional data, such as the inhibition of carbachol-stimulated phosphatidylinositol hydrolysis, on selected analogues confirmed the muscarinic antagonistic properties of this chemical series.
引用
收藏
页码:356 / 363
页数:8
相关论文
共 50 条
  • [41] A role for the M1 muscarinic receptor in gastrointestinal motility
    Jenkinson, Stephen
    Nottebaum, Lisa
    Bassyouni, Asser
    Lazzaro, John
    Pettersen, Betty
    Davoren, Jennifer
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [42] THE CLONING AND EXPRESSION OF THE RAT M1 MUSCARINIC RECEPTOR
    LAI, J
    CHUNG, FZ
    MEI, L
    GOCAYNE, JD
    ROESKE, WR
    YAMAMURA, HI
    VENTER, JC
    [J]. FASEB JOURNAL, 1988, 2 (04): : A599 - A599
  • [43] Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor
    Kozlowski, JA
    Lowe, DB
    Guzik, HS
    Zhou, GW
    Ruperto, VB
    Duffy, RA
    McQuade, R
    Crosby, G
    Taylor, LA
    Billard, W
    Binch, H
    Lachowicz, JE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2255 - 2257
  • [44] Acylhydrazones as M1/M3 selective muscarinic agonists
    Wu, ESC
    Kover, A
    Loch, JT
    Rosenberg, LP
    Semus, SF
    Verhoest, PR
    Gordon, JC
    Machulskis, AC
    McCreedy, SA
    Zongrone, J
    Blosser, JC
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (21) : 2525 - 2530
  • [45] Muscarinic preferential M1 receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats
    Tanda, Gianluigi
    Katz, Jonathan L.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 87 (04) : 400 - 404
  • [46] M1 MUSCARINIC ANTAGONISTS INTERACT WITH SIGMA-RECOGNITION SITES
    HUDKINS, RL
    DEHAVENHUDKINS, DL
    [J]. LIFE SCIENCES, 1991, 49 (17) : 1229 - 1235
  • [47] Inhibition of acetylcholine muscarinic M1 receptor function by the M1-selective ligand muscarinic toxin 7 (MT-7)
    Olianas, MC
    Maullu, C
    Adem, A
    Mulugeta, E
    Karlsson, E
    Onali, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (03) : 447 - 452
  • [48] EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF THE HUMAN M1 MUSCARINIC RECEPTOR IN SACCHAROMYCES-CEREVISIAE
    PAYETTE, P
    GOSSARD, F
    WHITEWAY, M
    DENNIS, M
    [J]. FEBS LETTERS, 1990, 266 (1-2) : 21 - 25
  • [49] MUSCARINIC M1 CONTRARY TO M2 ANTAGONISTS DO NOT INDUCE ANALGESIA
    GHELARDINI, C
    GIOTTI, A
    GUALTIERI, F
    MALCANGIO, M
    MALMBERGAIELLO, P
    SCAPECCHI, S
    BARTOLINI, A
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, : 99 - 99
  • [50] Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
    Avlani, Vimesh A.
    Langmead, Christopher J.
    Guida, Elizabeth
    Wood, Martyn D.
    Tehan, Ben G.
    Herdon, Hugh J.
    Watson, Jeannette M.
    Sexton, Patrick M.
    Christopoulos, Arthur
    [J]. MOLECULAR PHARMACOLOGY, 2010, 78 (01) : 94 - 104